Co-Diagnostics, Inc. (CODX)
4.595
-0.28
(-5.84%)
USD |
NASDAQ |
Jun 11, 12:23
Co-Diagnostics Shareholders Equity (Quarterly) : 16.04M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 16.04M |
| December 31, 2025 | 20.63M |
| September 30, 2025 | 39.83M |
| June 30, 2025 | 41.14M |
| March 31, 2025 | 47.92M |
| December 31, 2024 | 53.88M |
| September 30, 2024 | 63.78M |
| June 30, 2024 | 72.40M |
| March 31, 2024 | 78.35M |
| December 31, 2023 | 86.01M |
| September 30, 2023 | 99.49M |
| June 30, 2023 | 103.43M |
| March 31, 2023 | 110.63M |
| December 31, 2022 | 114.52M |
| September 30, 2022 | 134.95M |
| June 30, 2022 | 144.47M |
| March 31, 2022 | 147.71M |
| December 31, 2021 | 134.48M |
| September 30, 2021 | 100.16M |
| June 30, 2021 | 87.27M |
| March 31, 2021 | 76.26M |
| Date | Value |
|---|---|
| December 31, 2020 | 66.70M |
| September 30, 2020 | 52.78M |
| June 30, 2020 | 35.73M |
| March 31, 2020 | 19.17M |
| December 31, 2019 | 1.737M |
| September 30, 2019 | 3.334M |
| June 30, 2019 | 4.806M |
| March 31, 2019 | 5.564M |
| December 31, 2018 | -1.059M |
| September 30, 2018 | 0.1274M |
| June 30, 2018 | 1.243M |
| March 31, 2018 | 2.565M |
| December 31, 2017 | 3.850M |
| September 30, 2017 | 5.189M |
| June 30, 2017 | -4.395M |
| March 31, 2017 | -3.694M |
| December 31, 2016 | -2.995M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -1.147M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Fractyl Health, Inc. | 21.38M |
| Spectral AI, Inc. | -8.81M |
| Sangamo Therapeutics, Inc. | -18.96M |
| INmune Bio, Inc. | 19.62M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.50M |
| Total Liabilities (Quarterly) | 5.457M |
| Debt to Equity Ratio | 0.1266 |
| Current Ratio | 2.283 |
| Net Debt Paydown Yield | 0.36% |